The Key to Prostate Cancer: 30 Experts Explain 15 Stages of Prostate Cancer

by Mark Scholz

Overview

A Guide to Personalized Care. Patients face a real dilemma when selecting among so many treatments with potentially irreversible consquences. Studies show that treatment choices based on partial information often lead to regret.

When initally diagnosed with prostate cancer, the first step is to seek information. Patients struggle to pinpoint correct knowledge amidst a deluge of data overload. The "Paradox of Choice" can be diminished by staging the cancer accurately. The pathway leading out of this confusion is to know your Stage of Blue. With a short, self-administered prostate cancer staging quiz, Key directs readers to targeted information that is stage-specific.

This book directs patients to understand options and educate them about treatments specific for their stage of prostate cancer.

• A short STAGING QUIZ directs patients to their correct stage and which of the seven sections of the book to read.

• The book is divided into seven sections written by experts in prostate cancer. Five of the sections cover the FIVE STAGES OF BLUE.

• The average reader will only need to read three sections: Section I, which covers PSA, Gleason score and body scans, Section VII, which covers lifestyle and general health and only one of the additional sections--one that is related to that patient's prostate cancer stage.

Written by 30 leading experts and edited by a prostate oncologist, Key is a welcome antidote for an industry dominated by surgeons. This book helps patients and doctors work together on a level playing field to intelligently discuss the latest options.

Product Details

ISBN-13:	9780999065211
Publisher:	Prostate Oncology Specialists
Publication date:	01/31/2018
Pages:	492
Sales rank:	508,455
Product dimensions:	5.90(w) x 8.90(h) x 1.10(d)

About the Author

Mark Scholz, MD is the medical director of Prostate Oncology Specialists, Inc. He is also the executive director of the Prostate Cancer Research Institute. He received his medical degree from Creighton University, in Omaha, Nebraska. Dr. Scholz completed his internal medicine residency and medical oncology fellowship at the University of Southern California Medical Center. He is coauthor of Invasion of the Prostate Snatchers. He has authored over 20 scientific publications related to the treatment of prostate cancer.

Table of Contents

Preface A Path to Self-Education

Foreword Th e Paradox of Choice

Introduction Synopsis of Treatments

I. Staging and Prognosis

1. Quiz to Assign a Stage of Blue - Peter Scholz

2. Th e PSA Blood Test - Stanley Brosman, MD

3. Interpreting the Pathology Report - Jonathan Epstein, MD

4. Multiparametric MRI and Targeted Biopsy - Daniel Margolis, MD

5. Color Doppler Ultrasound and Targeted Biopsy - Duke Bahn, MD

6. Body Scans and Other Prognostic Factors - Fabio Almeida, MD

7. Picking the Right Doctor - Ralph Blum

II. The Sky Stage of Blue

8. Overview of Sky - Mark Scholz, MD

9. The Science Behind Active Surveillance - Laurence Klotz, MD

10. Focal Cryosurgery - Duke Bahn, MD

11. Introduction to Treatment-Related Side Effects - Mark Scholz, MD

12. Sexual Dysfunction - Kelly Chiles, MD and John Mulhall, MD

13. Surgical Side Effects Affecting Urination - Gary Leach, MD

14. Side Effects from Radiation Therapy - Henry Yampolsky, MD

15. Summary of Sky - Mark Scholz, MD

III. The Teal Stage of Blue

16. Overview of Teal - Mark Scholz, MD

17. Permanent Radioactive Seed Implants - Peter Grimm, DO and John Blasko, MD

18. High-Dose-Rate Seeds - D. Jeffrey Demanes, MD

19. IMRT for Teal - Zachary Zumsteg, MD and Howard Sandler, MD

20. Combination Therapy for Intermediate-Risk - Sean McBride, MD and Michael Zelefsky, MD

21. Proton Beam Therapy - Carl Rossi, MD

22. Stereotactic Body Radiation Therapy (SBRT) - Michael Steinberg, MD

23. TIP Alone as Primary Therapy for Teal - Mark Scholz, MD

24. Robotic Radical Prostatectomy - Timothy Wilson, MD

25. Comparing Treatments for Teal - Mark Scholz, MD

IV. The Azure Stage of Blue

26. Overview of Azure - Mark Scholz, MD

27. Testosterone Inactivating Pharmaceuticals (TIP) - Mark Scholz, MD

28. The Azure Stage of Prostate Cancer - Mark Scholz, MD

29. Unorthodox Therapies for High-Azure - Mark Scholz, MD

30. Reducing the Side Effects of TIP - Mark Scholz, MD

V. The Indigo Stage of Blue

31. Overview of Indigo - Mark Scholz, MD

32. Introduction to Radiation for Indigo - Christopher Rose, MD

33. Indigo—Cancer Relapse or Pelvic Node Disease - Mark Scholz, MD

34. Unorthodox Therapies for Indigo - Mark Scholz, MD

35. Minimizing the Side Effects of Chemotherapy - Richard Lam, MD

36. Indigo—Situations in which PSA is Misleading - Mark Scholz, MD

VI. The Royal Stage of Blue

37. Overview of Royal - Mark Scholz, MD

38. Early Hormonal Resistance: Low-Royal - Mark Scholz, MD

39. Oligometastatic Prostate Cancer: Basic-Royal - Jeffrey Turner, MD

40. Treatments for High-Royal - Richard Lam, MD

41. Unorthodox Therapies for Royal - Mark Scholz, MD

42. Immunotherapy for Prostate Cancer - Charles Drake, MD

43. Genetically Targeted Therapy - Mark Scholz, MD

44. Cancer Research: Striving to Live Longer and Better - Luke Nordquist, MD

45. Pain Management - Mark Scholz, MD

VII. Lifestyle and General Health Issues

46. Health Issues for Men with Prostate Cancer - Jeffrey Turner, MD

47. Whole Nutrition for Prostate Health and Recovery -Verne Varona

48. Fitness and Longevity - Mark Scholz, MD

49. Supplements for Prostate Cancer - Mark Moyad, MD

50. The Key: Knowing Your Stage of Blue - Mark Scholz, MD

Editorial Reviews

For men who wish to fight the fear of a prostate cancer diagnosis with knowledge, this is the book. -William Cassidy MD , Senator from Louisiana

This is the definitive reference for prostate cancer patients seeking to understand their disease and its treatment. - Charles “Snuffy” Myers, MD

Key to Prostate Cancer uses patient-friendly language to explain a complex and rapidly changing field. - David Hung, MD, Billionaire and Former CEO Medivation

From the Publisher

2018-10-03

A treatment-selection guide for the savvy prostate cancer patient.

Editor and author Scholz's (co-author: Invasion of the Prostate Snatchers, 2010) layman's guide to prostate cancer aims to help men to understand the severity of their ailment and to create a "personalized treatment plan" in concert with their physicians. The author is the executive director of the Prostate Cancer Research Institute and a physician who's treated prostate cancer for more than 20 years, and he's joined by a large cohort of other oncology experts, each of whom contributes chapters that define and discuss the "basic components" of prostate cancer diagnosis (including PSA [prostate specific antigen] levels, a Gleason score, prostate scans, and body scans). The crux of the guide, the "Five Stages of Blue," classifies newly diagnosed patients as either low-, intermediate-, or high-risk (Sky, Teal, or Azure, respectively) and veteran patients as either having a relapse (Indigo) or metastasis (Royal). Readers can skip ahead to the chapters that are most pertinent to their stage. The book's overall goal is to allow men to make prudent treatment decisions—and, especially, to help them avoid potentially irrevocable damage to their quality of life due to unnecessary surgery or radiation treatment. Most prostate cancer patients are referred to surgeons (primarily urologists); according to author Ralph Blum, there are fewer than 20 oncologists who specialize exclusively in this type of cancer, so this guide is necessary and useful. The multiple experts successfully provide context in patient-friendly but not overly simplistic terms. The book's pragmatic and systematic consideration of treatment options and risks will allow readers to make educated decisions. In short, the guide accomplishes what it set out to do: it "forewarn[s] and forearm[s]" patients about "industry biases" and "less-than-fully informed" physicians.

A practical, comprehensive, and authoritative work.

Kirkus Reviews